The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...

As previously reported by Medscape Medical News, the FDA recently rejected MDMA-assisted therapy for posttraumatic stress disorder (PTSD), citing inconsistent reporting across trials as a key ...

The psychedelic front line: how magic mushrooms and MDMA could cure ravaged soldiers’ PTSD - The hot topic at Psychedelic Science Conference 2025 was the potential for treating PTSD with MDMA ...

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is frustrated by the delay of approved treatments in the rare disease ...

The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a safety program to protect patients from risky drugs, for currently ...

RFK Jr. and Trump allies push for psychedelics to treat PTSD and depression. FDA in position to greenlight MDMA and psilocybin for mental health treatment.

A veteran advocating for the bill said psilocybin improved his PTSD symptoms after VA therapies failed to provide relief.

Lorde ’tried everything’ for her stage fright before turning to MDMA.

--NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced filing for the newly-announced FDA Commissioner's National Priority Voucher program on behalf of NRX-100 ...

FDA scrutinizing trials sending US patient cells to China Using informed consent to do what Congress couldn’t, the U.S. FDA is flexing its regulatory authority to halt clinical trials that involve ...